
    
      Study is looking at patients with diagnosed vitamin D deficiency (<20ng/mL). Participants are
      healthy adults between 18 and 75. No diagnosis of cancer, pregnancy, hypercalcemia,
      hyperparathyroidism, gastrointestinal absorption disorder, or chronic kidney disease and not
      taking medications for seizures or osteoporosis. Participants are randomized into two
      treatment groups: (1) 5,000IU cholecalciferol daily or (2) one-time 300,000 international
      units (IU) cholecalciferol. Vitamin D level, calcium level, and renal function are measure
      one week after initiating treatment and then at 3 months, 6 months, 9 months, and 12 months.
    
  